Symbol
Novavax, Inc.
Full name of the company.
MEDICAL-BIOMED/GENETICS
Industry name
DRUGS
Major industry name
Medical
Sector name
$7.34
Current price of the stock
$9M
Trading volume of the stock
$1.2B
Market capitalization of the company
Small Cap
Category of market capitalization
42.78%
Long-term growth mean estimate
3.86
Mean analyst rating
108.24%
Potential price appreciation based on analyst price targets
-
Percentage difference of EPS surprise
-
Dividend change over 1 year
$0.00
Shows the amount of dividend paid
-0.44
Total debt to total equity ratio
0.93
Current ratio
28.27%
Gross profit margin
-158.58%
Operating profit margin
-158.58%
Earnings before interest and taxes (EBIT) margin
-
Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin
-144.75%
Pretax profit margin
-143.53%
Net profit margin
23.04%
Measures profitability relative to shareholders' equity
18.57%
ROE excluding intangible assets
-7.08%
Measures profitability relative to total assets
40.06%
Measures profitability relative to invested capital
0.05
Asset turnover ratio
7.02
Inventory turnover ratio
0.89
Receivables turnover ratio
101.13
Average number of days it takes to collect receivables
-3.43
Measures valuation relative to earnings
-15.62
P/E based on future earnings estimates
1.33
Measures valuation relative to sales
-2.23
Measures valuation relative to book value
-1.28
Measures valuation relative to operating cash flow
-1.14
Measures valuation relative to free cash flow
0
Indicates company's M&A activity
© 2022 - 2025 QuantStrategy.io, Arizet Labs, LLC
